Scientific and medical news

Central sleep apnoea and inflammation are independently associated with arrhythmia in patients with heart failure

27.08.20131868

We examined whether the severity of central sleep apnoea (CSA) and the level of C-reactive protein are associated with the prevalence and complexity of arrhythmias, and whether these factors contribute to increased risk of nocturnal sudden death.

Independent Association between Nonalcoholic Fatty Liver Disease and Cardiovascular Disease: A Systematic Review and Meta-Analysis

26.08.20131796

Nonalcoholic fatty liver disease (NAFLD) is closely correlated with insulin resistance and several metabolic syndrome features, but whether it could increase the risk of cardiovascular disease remains undefined.

Long-term outcomes and cardiac surgery in critically ill patients with infective endocarditis

23.08.20131991

To assess long-term outcomes and the management of critical left-sided infective endocarditis (IE) and evaluate the impact of surgery.

Beyond Medication Prescription as Performance Measures: Optimal Secondary Prevention Medication Dosing After AMI ONLINE FIRST

22.08.20131897

To examine the prescribing patterns of medications quantified by the performance measures for acute myocardial infarction (AMI).

Blood Pressure and Mortality in U.S. Veterans With Chronic Kidney Disease: A Cohort Study

21.08.20131936

The ideal blood pressure (BP) to decrease mortality rates in patients with non–dialysis-dependent chronic kidney disease (CKD) is unclear.

Pharmacogenetics and statins: Genotyping might cut muscle-pain risk

20.08.20132039

Strikingly wide variation among patients in plasma levels of atorvastatin and rosuvastatin (Crestor, AstraZeneca), even with consistent dosing, is likely related to gene variants that affect the drugs' uptake by the liver in some patients, suggests a prospective study.

Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease

19.08.20132192

The first aim was to critically evaluate the extent to which familial hypercholesterolaemia (FH) is underdiagnosed and undertreated. The second aim was to provide guidance for screening and treatment of FH, in order to prevent coronary heart disease (CHD).